Tarsus Pharmaceuticals to buy Alkeus Pharmaceuticals (TARS:NASDAQ)
· seekingalpha.com
Tarsus (TARS) to acquire Alkeus for $450M upfront plus milestones, adding Stargardt drug gildeuretinol.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...